Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Better Standard for Sunscreen On the Way

By Drug Discovery Trends Editor | May 28, 2010

WASHINGTON (AP) – A clearer, more meaningful standard for sunscreen labels is coming soon to a lotion near you, but not in time for the summer beach season that kicks off this Memorial Day weekend.

The Food and Drug Administration is working to finish new labeling rules that have been years in the making, but not before October.

The current labeling system for sunscreen products is problematical, concedes Dr. James Spencer, spokesman for the American Academy of Dermatology. But as millions throng to the beaches, he counsels: “Sunscreen is the best you can do for now, and we’re working on better.”

The idea behind the new federal regulations is to make labels less confusing, so consumers know exactly what kind of protection they’re getting.

Most sunscreens on the market boast “broad spectrum UVA and UVB protection.” There’s a standard test to determine protection from the ultraviolet-B rays that cause sunburn – the familiar SPF rankings that tell people how long they can stay out in the sun before a burn.

But there is not a standard test to check protection from ultraviolet-A rays, the ones linked to cancer and wrinkles. That means it’s not clear how much UVA protection people are getting from their sunscreens.

The rules expected this fall would change that, with a standard testing protocol and a proposed four-star UVA rating system. It would spell out the protection level as “low,” ”medium,” ”high,” or “highest” – with one star representing low UVA protection, and four the highest protection available.

In the meantime, Spencer, a dermatologist in St. Petersburg, Fla., says people need to be sure to slather on plenty of sunscreen – a shot glass full of lotion for adults. Most people only put on about 25 to 50 percent of the lotion they need to protect them, he said.

He recommends a sunscreen with broad spectrum protection – UVA and UVB – and it should be at least an SPF 30.

Other tips:

-Apply sunscreen a half-hour before going outside. It takes that long to start working.

-Re-apply every few hours, especially if swimming or playing sports.

-Limit exposure during the peak UV hours of 10 a.m. to 4 p.m.

The four-star rating system for UVA protection was first proposed in 2007.

The FDA’s Dr. Matthew Holman says the agency received over 3,000 comments in response to the UVA-rating system, with many for and against.

The opposition said consumers will still find the label confusing because of the two separate rating systems, a numerical SPF rating for UVB and a four-star rating for UVA protection.

Holman, deputy director at FDA’s division of nonprescription regulation development, said the agency is still evaluating the comments. He would not say if the final rule would adopt the four-star system.

The new rules, as proposed, would also cap the highest SPF value at 50. Anything above that would be labeled “50 plus.”

Holman says it is not clear there’s an accurate test to prove sun protection factor above 50.

Date: May 27, 2010
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE